Clinical trial for Motor Disorders
Official title Non-invasive BCI-controlled Assistive Devices
ClinicalTrials.gov ID: NCT05183152
What this study is testing
- What it's testing
- The study wants to see if adding spinal stimulation or muscle stimulation helps people learn to control a BCI faster and better, especially for fine hand movements.
- Who it's for
- The study looks for adults with motor disorders such as spinal cord injury, stroke, or other movement‑related conditions.
- What's involved
- Participants will wear an EEG cap to record brain signals while they imagine moving their hand. They will receive either spinal electrical stimulation or muscle electrical stimulation that is timed with their imagined movements. The training will be done in a series of sessions that include BCI practice and related tests.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80. Healthy volunteers may be eligible.
You may be able to join if
- good general health
- normal or corrected vision
- no history of neurological/psychiatric disease
- ability to read and understand English (Research Personnel do not speak Spanish)
- people with motor disabilities
You likely can't join if
- people with motor disabilities
- short attentional spans or cognitive deficits that prevent the subject from concentrating during the whole experimental session
- heavy medication affecting the central nervous system (including vigilance)
- concomitant serious illness (e.g., metabolic disorders)
- All participants
- factors hindering EEG/EMG acquisition and the delivery of non-invasive electrical stimulation (e.g., skin infection, wounds, dermatitis, metal...
See the full eligibility criteria
- good general health
- normal or corrected vision
- no history of neurological/psychiatric disease
- ability to read and understand English (Research Personnel do not speak Spanish)
- people with motor disabilities
- motor deficits due to: unilateral and bilateral stroke / spinal cord injury / motor neuron diseases (i.e. amyotrophic lateral sclerosis, spino-cerebellar ataxia, multiple sclerosis) / muscular diseases (i.e.
- normal or corrected vision
- ability to read and understand English
- ability to provide informed consent
- people with motor disabilities
- short attentional spans or cognitive deficits that prevent the subject from concentrating during the whole experimental session
- heavy medication affecting the central nervous system (including vigilance)
- concomitant serious illness (e.g., metabolic disorders)
- All participants
- factors hindering EEG/EMG acquisition and the delivery of non-invasive electrical stimulation (e.g., skin infection, wounds, dermatitis, metal implants under electrodes)
- criteria identified in safety guidelines for MRI and TMS, in particular metallic implants
The study team makes the final eligibility decision.
Where it is enrolling
- Austin, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Austin, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.